Fig. 1 · Structure

Documents & Downloads

NLG919

Cat. No. A14322 CAS 1402836-58-1

IDO inhibitor

NLG919 is an orally available inhibitor of indoleamine 2,3-dioxygenase 1 (IDO1), with potential immunomodulating and antineoplastic activities.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
IDO (Cell-free assay) EC50 75 nM
IDO (Cell-free assay) EC50 75 nM

Cellular Effect

Cell Line Activity Value Description Reference
HeLa IC50 0.19 μM Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells assessed as reduction in kynurenine production using L-tryptophan as substrate incubated for 24 hrs [PMID: 31610376]
HeLa EC50 61 nM Inhibition of IDO1 in IFNgamma-stimulated human HeLa cells incubated for 24 hrs [PMID: 26642377]

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 1402836-58-1
Applications IDO inhibitor
Formula C18H22N2O
Molecular Weight 282.38
SMILES
C1CCC(CC1)C(CC2C3=CC=CC=C3C4=CN=CN24)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO Warmed: 13 mg/mL (46.03 mM)
Water Insoluble
Ethanol 26 mg/mL (92.07 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...